← All Sponsors
SPONSOR

Tenax Therapeutics, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Pulmonary Hypertension
NCT05983250 Phase 3
Recruiting

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Pulmonary Hypertension
United States, Canada View Trial →